Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vanessa Roldán-Schilling"'
Autor:
Fernando Alberca-de-las-Parras, Francisco Marín, Vanessa Roldán-Schilling, Fernando Carballo-Álvarez
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 107, Iss 5, Pp 289-306 (2015)
The use of antithrombotic drugs (anticoagulants and antiplatelets) has increased significantly with our understanding of cardiovascular risk. Encountering patients on these therapies who require an endoscopic procedure is therefore increasingly commo
Externí odkaz:
https://doaj.org/article/8a8b501c069747f3947054dc6f2903ad
Autor:
Francisco Marin, Marcelo Sanmartín Fernández, Iñaki Lekuona, Fernando Arribas, Gonzalo Barón-Esquivias, Vivencio Barrios, Juan Cosin-Sales, Román Freixa-Pamias, Jaime Masjuan, Alejandro I Pérez-Cabeza, Vanessa Roldán Schilling, José Manuel Vázquez Rodríguez, Carles Rafols Priu, Manuel Anguita Sánchez
Publikováno v:
Journal of Comparative Effectiveness Research. 11:1173-1184
Objective: To analyze the effectiveness and safety of rivaroxaban in patients with atrial fibrillation (AF). Methods: The clinical profile and outcomes of the EMIR study were indirectly compared with those of ROCKET-AF, eight other Spanish observatio
Autor:
Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, Vivencio Barrios, Iñaki Lekuona, Alejandro I Pérez-Cabeza, Jaime Masjuan, Esther Recalde del Vigo, José Manuel Vázquez Rodríguez, Roman Freixa-Pamias, Vanessa Roldán Schilling, Fernando Arribas, Carles Rafols Priu, Manuel Anguita Sánchez
Publikováno v:
Journal of Comparative Effectiveness Research. 12
Aim: It is not well known how comorbidities may change the prognosis of atrial fibrillation (AF) patients. This study was aimed to analyze the impact of cardiovascular disease on this population. Materials & methods: EMIR was a multicenter, prospecti
Autor:
Vanessa Roldán Schilling, Elena Garcia Martinez, Elisa García Garre, Silvia Garcia, Esther Navarro Manzano, Enrique Gonzalez Billalabeitia, Marta Zafra Poves, Gregory Y.H. Lip, Alejandra Ivars Rubio, Ginés Luengo Gil, Francisco Ayala de la Peña
Publikováno v:
Breast cancer research and treatment. 169(1)
Therapeutic exploitation of angiogenesis in breast cancer has been limited by the lack of reliable biomarkers. Circulating small-sized endothelial microparticles (sEMP) are likely to play a significant role as messengers of angiogenesis. Higher level
Publikováno v:
Medicina Clínica. 139:10-12
Thromboembolic disease, both arterial and venous, is a major cause of morbidity and mortality in developed countries. The new anticoagulants exert their action by selective, direct and reversible inhibition of a single coagulation factor. Although th
Autor:
Luis de Teresa Parreño, Pascual Marco Vera, Francisco Marín Ortuño, Vanessa Roldán Schilling, Javier Pineda Rocamora, Vicente Climent Payá, Juan Gabriel Martínez Martínez, Francisco Sogorb Garri
Publikováno v:
Revista Española de Cardiología. 54:1155-1160
Introduccion En raras ocasiones se indica el tratamiento anticoagulante en pacientes con disfuncion sistolica de origen isquemico, en ritmo sinusal. Sin embargo, teoricamente podrian estar presentes los 3 brazos que inician el proceso trombotico (tri
Autor:
Francisco Marín Ortuño, Pascual Marco Vera, Vanessa Roldán Schilling, Ramiro Calatayud Sendra, Antonio Toral Noguera, Juan Gabriel Martínez Martínez, Francisco Sogorb Garri, Fernando García de Burgos Rico
Publikováno v:
Revista Española de Cardiología. 52:25-30
Introduccion y objetivos. Los pacientes con fibrilacion auricular reumatica poseen un alto riesgo de embolismo, por lo que se recomienda la anticoagulacion de forma continuada. En ellos apenas se ha estudiado la funcion fibrinolitica, ni la influenci
Publikováno v:
Medicina clinica. 139
Thromboembolic disease, both arterial and venous, is a major cause of morbidity and mortality in developed countries. The new anticoagulants exert their action by selective, direct and reversible inhibition of a single coagulation factor. Although th